This is the authors' abstract. We don't add key points for this paper.
The nuclear data required for the production and endotherapeutic application of radionuclides are outlined. The three types of therapeutic radionuclides, viz. β - -emitters, α-emitters and Auger electron emitters, are considered and the role of some β + -emitters in therapy planning is discussed. The status of available data is reviewed.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
S.M. Qaim (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: